Severity of COVID-19 reinfection linked to severity of initial infection
Jul 18, 2024
Individuals who experienced severe initial and first reinfection were older in age and had a higher mortality risk.
Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 Infection
Jul 18, 2024
No significant reduction was seen in the risk for symptomatic SARS-CoV-2 infection with postexposure prophylaxis for five or 10 days.
Hospital-onset SARS-CoV-2 infection during omicron linked to morbidity
Jul 15, 2024
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
Nearly one in four do not recover from COVID-19 by 90 days
Jun 19, 2024
Female sex and preexisting cardiovascular disease were tied to longer recovery times.
Residual risk seen for death, postacute sequelae in third year after COVID-19 hospitalization
Jun 13, 2024
The risk for death remains significantly elevated in the third year, as is risk for incident postacute sequelae of COVID-19.
Expert panel develops new definition of long COVID
Jun 11, 2024
A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.
Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.
Identifying highest-risk assisted living communities key to tackling next outbreak: report
By
Kimberly Bonvissuto
May 22, 2024
The public health response to COVID-19 in assisted living communities in New York highlights the need to identify those communities at highest risk of infectious disease outbreaks to provide necessary...
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
Long-term smell, but not taste, deficits seen after COVID-19
May 01, 2024
The deficits appear to be the greatest for individuals with the original untyped and alpha variant infections.